Elsevier

NeuroImage

Volume 17, Issue 1, September 2002, Pages 302-316
NeuroImage

Regular Article
Discrimination between Alzheimer Dementia and Controls by Automated Analysis of Multicenter FDG PET

https://doi.org/10.1006/nimg.2002.1208Get rights and content

Abstract

A new diagnostic indicator of FDG PET scan abnormality, based on age-adjusted t statistics and an automated voxel-based procedure, is presented and validated in a large data set comprising 110 normal controls and 395 patients with probable Alzheimer's disease (AD) that were studied in eight participating centers. The effect of differences in spatial resolution of PET scanners was minimized effectively by filtering and masking. In controls FDG uptake declined significantly with age in anterior cingulate and frontolateral perisylvian cortex. In patients with probable AD decline of FDG uptake in posterior cingulate, temporoparietal, and prefrontal association cortex was related to dementia severity. These effects were clearly distinct from age effects in controls, suggesting that the disease process of AD is not related to normal aging. Women with probable AD had significantly more frontal metabolic impairment than men. The new indicator of metabolic abnormality in AD-related regions provided 93% sensitivity and specificity for distinction of mild to moderate probable AD from normals, and 84% sensitivity at 93% specificity for detection of very mild probable AD (defined by Mini Mental Score 24 or better). All regions related to AD severity were already affected in very mild AD, suggesting that all vulnerable areas are affected to a similar degree already at disease onset. Ventromedial frontal cortex was also abnormal. In conclusion, automated analysis of multicenter FDG PET is feasible, provides insights into AD pathophysiology, and can be used potentially as a sensitive biomarker for early AD diagnosis.

References (58)

  • A. Alavi et al.

    Quantitative analysis of PET and MRI data in normal aging and Alzheimer's disease: Atrophy weighted total brain metabolism and absolute whole brain metabolism as reliable discriminators

    J. Nucl. Med.

    (1993)
  • C.C. Chu et al.

    The autonomic-related cortex: Pathology in Alzheimer's disease

    Cereb. Cortex

    (1997)
  • M.J. de Leon et al.

    Prediction of cognitive decline in normal elderly subjects with 2-F-18-fluoro-2-deoxy-d-glucose positron-emission tomography (FDG PET)

    Proc. Natl. Acad. Sci.USA

    (2001)
  • B. Desgranges et al.

    The neural substrates of memory systems impairment in Alzheimer's disease. A PET study of resting brain glucose utilization

    Brain

    (1998)
  • R. Fama et al.

    Selective cortical and hippocampal volume correlates of Mattis Dementia Rating Scale in Alzheimer disease

    Arch. Neurol.

    (1997)
  • K.J. Friston et al.

    Spatial registration and normalisation of images

    Human Brain Mapping

    (1995)
  • K.J. Friston et al.

    Statistical parametric maps in functional imaging: a general linear approach

    Human Brain Mapping

    (1995)
  • C.L. Grady et al.

    Quantitative comparison of cerebral glucose metabolic rates from two positron emission tomographs

    J. Nucl. Med.

    (1989)
  • F. Grigoletto et al.

    Norms for the Mini-Mental State Examination in a healthy population

    Neurology

    (1999)
  • E. Grober et al.

    Screening for dementia by memory testing

    Neurology

    (1988)
  • J.V. Haxby et al.

    Relations between neuropsychological and cerebral metabolic asymmetries in early Alzheimer's disease

    J. Cereb. Blood Flow Metab.

    (1985)
  • J.V. Haxby et al.

    Longitudinal study of cerebral metabolic asymmetries and associated neuropsychological patterns in early dementia of the Alzheimer type

    Arch. Neurol.

    (1990)
  • V.W. Henderson et al.

    Cognitive deficits of men and women with Alzheimer's disease

    Neurology

    (1994)
  • K. Herholz

    FDG PET and differential diagnosis of dementia

    Alzheimer Dis. Assoc. Disorders

    (1995)
  • K. Herholz et al.

    Criteria for the diagnosis of Alzheimer's disease with positron emission tomography

    Dementia

    (1990)
  • K. Herholz et al.

    Impairment of neocortical metabolism predicts progression in Alzheimer's disease

    Dementia Geriatr. Cog. Disord.

    (1999)
  • K. Herholz et al.

    Comparability of FDG PET studies in probable Alzheimer's disease

    J. Nucl. Med.

    (1993)
  • J.M. Hoffman et al.

    FDG PET imaging in patients with pathologically verified dementia

    J. Nucl. Med.

    (2000)
  • Cited by (0)

    1

    To whom correspondence should be addressed at Max-Planck-Institut für neurologische Forschung, Gleueler Str. 50, 50931 Köln, Germany. Fax: +49-221-4726-298. E-mail: [email protected].

    View full text